A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.

Study NCT00544960 Information provided by Ascenta Therapeutics

First Received: October 12, 2007 Last Updated: July 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2009
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)